Cited by 10Erythropoietin and Anemia TreatmentHormonal Regulation and HypertensionAdrenal Hormones and Disorders

Adrenocorticotropic hormone, blood pressure, and serum erythropoietin concentrations in the rat

Zhang, Y·2004·American Journal of Hypertension

Abstract

BACKGROUND: This study was designed to investigate the effects of adrenocorticotropic hormone (ACTH) on systolic blood pressure (BP) and serum erythropoietin (EPO) concentrations in two strains of rats. We hypothesized that ACTH-induced hypertension in the rat is characterized by increased EPO production. METHODS: Male Sprague-Dawley (SD) and Wistar out-bred (Wistar) rats were treated with saline or ACTH (0.2 mg/kg/d). Systolic BP was measured using the tail-cuff method. Serum EPO concentrations were assayed using an ELISA kit for human EPO, which cross-reacts with but underestimates rat EPO. Thymus weight was used as a marker of glucocorticoid activity. RESULTS: In SD rats, ACTH increased systolic BP (from 109 +/- 4 to 142 +/- 5 mm Hg, P <.0005), significantly greater than in saline-treated rats (P <.01). Systolic BP in ACTH-treated Wistar increased from 120 +/- 3 to 133 +/- 4 mm Hg (P <.05), but was not significantly different from saline-treated Wistar rats. The ACTH-induced increase in systolic BP was greater in SD than in Wistar rats (P <.05). Serum EPO levels were 5.6 +/- 0.4 in SD and 5.9 +/- 0.3 IU/L in Wistar rats, and decreased to undetectable levels with ACTH treatment in 10 of 10 SD and 7 of 10 Wistar rats. The ACTH treatment increased hemoglobin and hematocrit, and decreased thymus weight in both strains. CONCLUSIONS: 1) ACTH decreased serum EPO concentrations in both strains; 2) EPO is inversely related to ACTH-induced hypertension in the rat; and 3) Wistar rats are relatively resistant to the BP raising effects of ACTH treatment but not to the ACTH-induced decrease in thymus weight. These data suggest that EPO is not causal in ACTH-induced hypertension.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.amjhyper.2004.01.004

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Chronic high circulating levels of ACTH, caused by excess anterior pituitary secretion such as Cushing's disease or by infusion of ACTH, are associated with hypertension in humans and experimental animals.

    “Chronic high circulating levels of ACTH, caused by excess anterior pituitary secretion (e.g. Cushing’s disease) or by infusion of ACTH, are associated with hypertension in humans and experimental animals [10–12].”

    From Role of the brain melanocortins in blood pressure regulation (2017) · cites this paper as [11]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Criswell KA, Sulkanen AP, Hochbaum AF, Bleavins MR: Effects of phenylhydrazine or phlebotomy on peripheral blood, bone marrow and erythropoietin in Wistar rats. J Appl Toxicol 2000;20:25-34.

Cited by

Sorted by citations

Authors
Zhang, Y.
Affiliations
Australian National University (AU)
Corresponding author
Zhang, Y
Venue
American Journal of Hypertension
Published
2004-05
Volume
17
Issue
5
Pages
457-461
ISSN
0895-7061 (ISSN-L)
OpenAlex
W1984276414
Cited by
10
References
31
Citations by year
2020: 1 · 2017: 2 · 2013: 1
FWCI
1.05
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Hypertension (publishedVersion)
  • PubMed (publishedVersion)
  • ANU Open Research (Australian National University) (submittedVersion)
Funders
Novartis Australia
Topics
  • Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
ACTH, ACTH-induced hypertension, erythropoietin, systolic blood pressure, rat strain differences, Sprague-Dawley rats, Wistar rats, thymus weight, glucocorticoid activity, hemoglobin, hematocrit, rat model of hypertension
MeSH terms
Adrenocorticotropic Hormone, Animals, Blood Glucose, Blood Pressure, Body Weight, Erythropoietin, Hematocrit, Hemoglobins, Injections, Intravenous, Male, Models, Cardiovascular, Placebos, Sodium Chloride, Systole, Thymus Gland, Biomarkers, Rats, Sprague-Dawley, Rats, Wistar, Models, Animal, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review